Key result
Medication regimen complexity in patients with kidney failure was significantly linked to poor health outcomes, including poor quality of life, frailty, hospitalization, and mortality.
Why the study?
The significant medication burden required to manage kidney failure comorbidities and complications may impact patient-reported and clinical outcomes, but methods to assess complexity and effective interventions needed systematic review.
Does medication regimen complexity impact patient-reported and clinical outcomes in adults with kidney failure?
Systematic Review
Does medication regimen complexity impact patient-reported and clinical outcomes in adults with kidney failure?
Medication regimen complexity in kidney failure is significantly associated with poor clinical and patient-reported outcomes, highlighting the need for de-prescribing and pharmacist-led management.
Supports deprescribing and pharmacist-led management in kidney failure; extends evidence on regimen complexity as a modifiable risk factor.
INTRODUCTION: Kidney failure is a life-limiting condition that profoundly impacts an individual's quality of life. The significant medication burden on patients required to manage the comorbidities and complications of kidney failure can have implications for patient-reported and clinical outcomes. METHODS: This work systematically reviewed methods used to assess medication regimen complexity amongst adults with kidney failure, the associated patient-reported and clinical outcomes, and the effectiveness of interventions to address regimen complexity. A comprehensive search of PubMed, Embase, Web of Science, and Scopus covering all relevant literature up until November 2023 was performed. RESULTS: The findings of this review suggest that patients with kidney failure are prescribed complex medication regimens, which have implications for both clinical and patient-related outcomes. A significant link was found between regimen complexity and poor health outcomes, particularly in the dialysis-dependent patient population. These outcomes included poor quality of life, medication adherence, frailty, hospitalization, and mortality. Interventions to improve medication regimen complexity included de-prescribing tools and pharmacist-led medication management services. CONCLUSION: Future research should consider well-designed prospective longitudinal studies that develop more comprehensive and standardized definitions of medication regimen complexity. Additionally, multifaceted interventions are needed to address the complex medication regimen to improve outcomes in patients with kidney failure.
No takes yet. Share an insight, caveat, or question.
Goh et al. (2025) conducted a systematic review in Kidney failure. Medication regimen complexity was evaluated on Patient-reported and clinical outcomes (quality of life, medication adherence, frailty, hospitalization, and mortality). Medication regimen complexity in patients with kidney failure was significantly linked to poor health outcomes, including poor quality of life, frailty, hospitalization, and mortality.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: